Sum of respective reporting
variables per period. RR = relative risk of variable occurring compared
with baseline period P1. Total = total number of reports, NMBA = number
of reactions where neuromuscular blocking agents were used, IgE-SUX and
IgE-HEX = number of reactions where the presence of serum IgE antibodies
to SUX and HEX (≥0.35 kUA/l), respectively, was documented at the time
of reaction. Of the parenthesized values, NMBA, IgE-SUX and IgE-HEX is
calculated percentages from total, while parenthesized values of Total
denote cases per 100 000 anesthesias. The statistics are calculated
using 500 000 stipulated general anesthesias per year.
† Chi-squared test.
|
Sum of respective reporting
variables per period. RR = relative risk of variable occurring compared
with baseline period P1. Total = total number of reports, NMBA = number
of reactions where neuromuscular blocking agents were used, IgE-SUX and
IgE-HEX = number of reactions where the presence of serum IgE antibodies
to SUX and HEX (≥0.35 kUA/l), respectively, was documented at the time
of reaction. Of the parenthesized values, NMBA, IgE-SUX and IgE-HEX is
calculated percentages from total, while parenthesized values of Total
denote cases per 100 000 anesthesias. The statistics are calculated
using 500 000 stipulated general anesthesias per year.
† Chi-squared test.
|
Sum of respective reporting
variables per period. RR = relative risk of variable occurring compared
with baseline period P1. Total = total number of reports, NMBA = number
of reactions where neuromuscular blocking agents were used, IgE-SUX and
IgE-HEX = number of reactions where the presence of serum IgE antibodies
to SUX and HEX (≥0.35 kUA/l), respectively, was documented at the time
of reaction. Of the parenthesized values, NMBA, IgE-SUX and IgE-HEX is
calculated percentages from total, while parenthesized values of Total
denote cases per 100 000 anesthesias. The statistics are calculated
using 500 000 stipulated general anesthesias per year.
† Chi-squared test.
|
Sum of respective reporting
variables per period. RR = relative risk of variable occurring compared
with baseline period P1. Total = total number of reports, NMBA = number
of reactions where neuromuscular blocking agents were used, IgE-SUX and
IgE-HEX = number of reactions where the presence of serum IgE antibodies
to SUX and HEX (≥0.35 kUA/l), respectively, was documented at the time
of reaction. Of the parenthesized values, NMBA, IgE-SUX and IgE-HEX is
calculated percentages from total, while parenthesized values of Total
denote cases per 100 000 anesthesias. The statistics are calculated
using 500 000 stipulated general anesthesias per year.
† Chi-squared test.
|
Sum of respective reporting
variables per period. RR = relative risk of variable occurring compared
with baseline period P1. Total = total number of reports, NMBA = number
of reactions where neuromuscular blocking agents were used, IgE-SUX and
IgE-HEX = number of reactions where the presence of serum IgE antibodies
to SUX and HEX (≥0.35 kUA/l), respectively, was documented at the time
of reaction. Of the parenthesized values, NMBA, IgE-SUX and IgE-HEX is
calculated percentages from total, while parenthesized values of Total
denote cases per 100 000 anesthesias. The statistics are calculated
using 500 000 stipulated general anesthesias per year.
† Chi-squared test.
|
Sum of respective reporting
variables per period. RR = relative risk of variable occurring compared
with baseline period P1. Total = total number of reports, NMBA = number
of reactions where neuromuscular blocking agents were used, IgE-SUX and
IgE-HEX = number of reactions where the presence of serum IgE antibodies
to SUX and HEX (≥0.35 kUA/l), respectively, was documented at the time
of reaction. Of the parenthesized values, NMBA, IgE-SUX and IgE-HEX is
calculated percentages from total, while parenthesized values of Total
denote cases per 100 000 anesthesias. The statistics are calculated
using 500 000 stipulated general anesthesias per year.
† Chi-squared test.
|
Sum of respective reporting
variables per period. RR = relative risk of variable occurring compared
with baseline period P1. Total = total number of reports, NMBA = number
of reactions where neuromuscular blocking agents were used, IgE-SUX and
IgE-HEX = number of reactions where the presence of serum IgE antibodies
to SUX and HEX (≥0.35 kUA/l), respectively, was documented at the time
of reaction. Of the parenthesized values, NMBA, IgE-SUX and IgE-HEX is
calculated percentages from total, while parenthesized values of Total
denote cases per 100 000 anesthesias. The statistics are calculated
using 500 000 stipulated general anesthesias per year.
† Chi-squared test.
|